Clebopride malate

Clebopride malate (CAS No.: 57645-91-7) is a synthetic small molecule dopamine receptor antagonist, primarily classified as a neurogastroenterology research compound for studies of gastrointestinal motility regulation and emesis related signaling, with principal activity reported at dopamine D2 receptor mediated pathways and downstream modulation of cholinergic neurotransmission in the enteric nervous system; within biomedical research workflows it is commonly used as a reference pharmacology tool to interrogate dopaminergic control of gut function, receptor level mechanism studies, and translational assay development in functional gastrointestinal disorder models, while available literature descriptions indicate pharmacological activity generally in the nanomolar to micromolar range for dopamine antagonist class effects depending on assay system and endpoint, and in the absence of uniformly reported assay harmonization for every model, experimental concentrations or dosing regimens should be selected according to specific study design, biological matrix, and objective readouts in cell based systems, ex vivo tissue preparations, animal models, and compound screening platforms focused on receptor pharmacology, pathway validation, and mechanism informed drug discovery research.